Yang Ye
Associate Research Scientist in Epidemiology (Microbial Diseases)About
Research
Publications
2025
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
Sumsuzzman D, Ye Y, Wang Z, Pandey A, Langley J, Galvani A, Moghadas S. Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis. BMC Infectious Diseases 2025, 25: 215. PMID: 39948450, PMCID: PMC11827239, DOI: 10.1186/s12879-025-10610-5.Peer-Reviewed Original ResearchConceptsPopulation settingEffective public health strategiesConfidence intervalsImpact of disease severityModified Newcastle-Ottawa ScalePublic health strategiesHigher secondary attack rateRisk of biasNewcastle-Ottawa ScalePandemic responseGlobal systematic reviewRandom-effects modelFreeman-Tukey double arcsine transformationWeb of ScienceNo significant associationDrivers of SARS-CoV-2 transmissionHealth strategiesSecondary attack rateSARS-CoV-2Disease severityEffective pandemic responseTargeted interventionsDouble arcsine transformationOvid MEDLINESystematic reviewIntegrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges
Ye Y, Pandey A, Bawden C, Sumsuzzman D, Rajput R, Shoukat A, Singer B, Moghadas S, Galvani A. Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges. Nature Communications 2025, 16: 581. PMID: 39794317, PMCID: PMC11724045, DOI: 10.1038/s41467-024-55461-x.Peer-Reviewed Original ResearchConceptsArtificial intelligenceEffective public health planningPublic health planningMechanistic modelSystematic search strategyCapabilities of artificial intelligenceData-mining capabilitiesReview of opportunitiesFusion of AIPotential of AIHealth plansSpectrum of infectious diseasesDisease dynamics
2024
Estimating the lives that could be saved by expanded access to weight-loss drugs
Pandey A, Ye Y, Wells C, Singer B, Galvani A. Estimating the lives that could be saved by expanded access to weight-loss drugs. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2412872121. PMID: 39405358, PMCID: PMC11513960, DOI: 10.1073/pnas.2412872121.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide-1Body mass index categoriesObesity prevalence dataGlucagon-like peptide-1 receptor agonistsHazard ratio of mortalityRatio of mortalityPublic health impactWeight loss drugsInsurance coverage issuesGastric inhibitory polypeptideHealthcare accessType 2 diabetesUnited StatesPublic health crisisObesity epidemicReceptor agonistsIndex categoriesHazard ratioPrevalence dataInhibitory polypeptidePeptide-1Health impactsNovel treatmentObesityHealth crisis
News
Get In Touch
Contacts
Email